Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Bendroflumethiazide 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendrofluazide+potassium 2.5mg/7.7Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 5 milligram and nadolol 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendroflumethiazide 2.5 mg and timolol maleate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendroflumethiazide + nadolol 5mg/40mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Bendroflumethiazide + nadolol 5mg/80mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|
Propranolol hydrochloride + bendrofluazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bendrofluazide - chemical |
Inferred relationship |
Some |
|